2 UK growth and value stocks I’d buy to hold until 2030!

I think these value stocks are too good for growth investors to ignore. I reckon they could deliver exceptional returns through to the end of the decade.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian man drinking coffee at home and looking at his phone

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here are two top UK growth and value stocks I’m looking to buy when I have spare cash to invest.

Spire Healthcare

Chronic underfunding in the NHS has led to an explosion in waiting lists. It’s why I’ve opened a position in private hospital operator Spire Healthcare (LSE:SPI) and plan to buy more.

Research from the Private Healthcare Information Network shows that a record 272,000 patients funded medical treatment themselves last year. The number of people receiving care through insurance policies is also booming as NHS waiting lists grow. Latest data showed a record 7.33m people awaiting state-funded treatment.

Spire — which owns 39 hospitals and 33 clinics across the country — continues to make solid progress against this backdrop. It said this month its “good momentum” has continued since the end of last year. In 2022, the business saw revenues rise 8.3% to £1.2bn, while adjusted operating profit leapt 30.2% year on year to £105.6m.

Staff shortages and the upward pressure this is placing on wages is affecting profits here. But price rises, along with a favourable treatment mix and cost savings, mean the business keeps making exceptional progress when it comes to margins. Its adjusted EBITDA margin improved 90 basis points last year to 17%.

City analysts expect annual earnings to rise 48% in 2023. They predict bottom-line rises of 61% and 33% too, in 2024 and 2025 respectively, as the NHS patient exodus continues.

And these predictions leave Spire trading on a forward price-to-earnings growth (PEG) ratio of just 0.8. Any reading below 1 suggests a stock is undervalued.

Redcentric

Purchasing tech stocks could be another good idea as the pivot towards flexible working gathers pace. Redcentric (LSE:RCN) is one such London-listed company on my radar.

Employee demands for an improved work/life balance have soared since Covid. And huge labour shortages across the West mean that businesses are having to bend to worker demands, including working from home.

Lawmakers are taking steps to help workers stay away from the office too. In the UK, for example, The Employment Relations (Flexible Working) Bill that’s going through parliament will allow people to request flexible working from Day One of their employment.

This all bodes well for Redcentric. The business provides cloud computing services that allow workers to access, manage and share project data from anywhere. It also provides expertise in cyber security, communications and other areas critical for effective and safe flexible working. This helped revenues rise 52% in the last financial year (to March) to $141.8m.

Smaller operators like this face huge competition from industry giants such as Microsoft. But the exceptional progress it has made so far still makes it an attractive stock to own, in my opinion.

Analysts expect annual earnings here to rise 96% in financial 2024. This leaves the tech firm trading on a PEG ratio of just 0.1.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has recommended Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Photo of a man going through financial problems
Investing Articles

Is a stock market crash coming? And what should I do now?

Global investors are panicking about a new US stock market crash in the days or weeks ahead. Here's how I'm…

Read more »

Investing Articles

FTSE shares: a brilliant opportunity for investors to get rich?

With valuations in the US looking full, Paul Summers thinks there's a good chance that FTSE stocks might become more…

Read more »

Growth Shares

2 FTSE 100 stocks that could outperform the index in 2025

Jon Smith flags up a couple of FTSE 100 stocks that have strong momentum right now and have beaten the…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 stock market mistake to avoid in 2025

This Fool has been battling bouts of of FOMO recently, as one of his growth shares enjoys a big bull…

Read more »

Investing Articles

2 no-brainer buys for my Stocks and Shares ISA in 2025

Harvey Jones picks out a couple of thriving FTSE 100 companies that he's keen to add to his Stocks and…

Read more »

Number three written on white chat bubble on blue background
Investing For Beginners

3 investing mistakes to avoid when buying UK shares for 2025

Jon Smith flags up several points for investors to note when it comes to thinking about which UK shares to…

Read more »

Investing Articles

Will the rocketing Scottish Mortgage share price crash back to earth in 2025?

The recent surge in the Scottish Mortgage share price caught Harvey Jones by surprise. He was on the brink of…

Read more »

Investing Articles

2 cheap shares I’ll consider buying for my ISA in 2025

Harvey Jones will be on the hunt for cheap shares for his ISA in 2025 and these two unsung FTSE…

Read more »